Robotic Gait Training for Stroke
(ERA Stroke Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether robotic gait training (RGT) or usual care (UC) better aids walking recovery after a stroke. Participants who recently experienced a stroke and are in early recovery will receive either RGT, which involves walking practice with a robotic device, or UC, which involves traditional physical therapy. The research aims to determine which method more effectively improves walking. Ideal participants are those recovering from a stroke, are medically stable, and are undergoing rehabilitation at Baylor Scott & White Institute for Rehabilitation with the goal of walking again. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance stroke recovery therapies.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that robotic gait training is safe for stroke patients?
Research has shown that robotic walking training is generally safe for stroke patients. A review of several studies found that adding robotic-assisted walking training to regular physical therapy can double the chances of walking recovery, suggesting the treatment is well-tolerated. Another study highlighted that this type of training is promising for helping patients regain function after a stroke.
Most studies indicate that robotic walking training is as effective as traditional physical therapy in improving balance. While these studies focus on its effectiveness, they also suggest that the treatment does not cause significant harm. No major reports of negative effects or side effects have been noted, indicating it is safe to use.12345Why are researchers excited about this trial?
Robotic Gait Training is unique because it uses robotic technology to assist stroke patients in walking, which is different from standard physical therapy that relies solely on human guidance. This approach allows for precise control over movement patterns and intensity, potentially leading to more efficient and effective rehabilitation. Researchers are excited about this treatment because the robotic assistance can provide consistent, repeatable movements that may accelerate recovery and improve walking ability more than traditional methods.
What evidence suggests that robotic gait training is effective for stroke recovery?
This trial will compare Robotic Gait Training (RGT) with usual care gait training for stroke recovery. Studies have shown that RGT can significantly aid stroke recovery. Research indicates that RGT improves walking, balance, and stamina in stroke survivors. One study found that robotic training enhanced lower body function more than traditional walking exercises. Another study suggested that robotic devices like the Lokomat® assist with balance recovery, offering benefits similar to regular physical therapy. Overall, strong evidence supports using RGT to help stroke patients regain mobility.16789
Are You a Good Fit for This Trial?
This trial is for stroke patients aged 18-85 in the early recovery phase who have the potential to regain walking ability. Participants must be medically stable, able to fit into a robotic exoskeleton, and managing continence. It excludes those with severe cognitive issues, pregnancy, or other neurological conditions like TBI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either robotic gait training or usual care gait training for 90 minutes each week during their inpatient rehabilitation stay
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at discharge, 1 month, and 3 months post-discharge
What Are the Treatments Tested in This Trial?
Interventions
- Robotic Gait Training
Robotic Gait Training is already approved in European Union, United States, Canada, Switzerland for the following indications:
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
- Spinal cord injury
- Cerebral palsy
- Stroke
- Multiple sclerosis
- Parkinson’s disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor Research Institute
Lead Sponsor
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator